Alta Sciences

JANUARY 31, 2025

Their passion and curiosity to expand the boundaries of toxicology research illuminated the room. As experts in early-phase drug development , from discovery through Phase II clinical research , we at Altasciences can share with STC members our accumulated knowledge and experience, and provide mentorship for future toxicologists.

Cell Biology 52

Cell Biology Pharmaceutical Companies Clinical Research Government 52

Vial

FEBRUARY 29, 2024

However, despite their increasingly ubiquitous role in the clinical research industry, the question remains as to the extent of their participation. That is, how many clinical trials are actually managed by these organizations? billion, projected to grow at a compound annual growth rate (CAGR) of 6.9% between 2023 and 2032.

Clinical Trials 52

Clinical Trials Trials Clinical Research Drug Development 52

The Premier Consulting Blog

NOVEMBER 20, 2023

years after publication; no earlier than October 1, 2027) End of Enforcement Discretion for: Premarket review for high-risk IVDs. Our team is helping clients navigate the changing regulations and clinical research. Phase 4 (3.5

Laboratories 52

Laboratories Clinical Development FDA Regulations 52

Vial

DECEMBER 7, 2023

billion by 2027 , at a compound annual growth rate (CAGR) of 45.7% Vial is a full-service CRO that also recognizes the role of technology in the future of clinical research and recently launched its AI-based drug discovery arm, Battery Bio. This is evident in the estimated market value for AI in drug discovery, which was US$0.6

Drugs 52

Drugs Clinical Trials Trials Treatment 52

Agency IQ

FEBRUARY 21, 2024

Given the widespread use of CDISC for clinical research and HL7 for electronic health record (EHR) data, the two organizations have partnered to create mapping guides to streamline the flow of data from EHRs to CDISC submission-ready datasets, and vice versa. CMS in the United States ).

Science 40

Science Regulations International FDA 40